Relay Therapeutics
- Relay uncloaks with $57M Series A round to join the next-gen cancer race
- FierceBiotech’s 2017 Fierce 15
- Relay Therapeutics Secures $400 Million in Series C Financing
** Nimbus Therapeutics**
**
- Discovering Nimbus
- Nimbus Discovery Secures $24 Million Series A Financing
- Gilead Sciences Announces Acquisition of Nimbus Therapeutics’ Acetyl-CoA Carboxlyase (ACC) Program for NASH and Other Liver Diseases
- Nimbus Delivers Its Apollo Mission: A $1.2B Gilead Partnership
- Nimbus Therapeutics Announces $65 Million in New Financing to Accelerate Pipeline Progress and Expand Discovery Efforts
**
